FDAClass IIDecember 4, 2024

Theracare Maximum Strength Pain Relief 4% Lidocaine recall: CGMP Deviations

THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC…

Why was Theracare Maximum Strength Pain Relief 4% Lidocaine recalled?

cGMP Deviations

What should I do if I have this product?

Review the official FDA enforcement record for current instructions.

What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.

Is my product affected?

Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.

Which lot codes, UPCs or models are affected?

a) UPC 8 45717 00878 5 b) UPC 8 45717 01056 6

Product
THERACARE MAXIMUM STRENGTH PAIN RELIEF 4% LIDOCAINE PATCH, a) 1 patch (NDC 71101-001-24, UPC 8 45717 00878 5) and b) 6 patches (NDC 71101-001-06, UPC…
Recalling firm
Unexo Life Sciences Private Limited
Quantity
455,536 patches
Distribution
Nationwide in the US
Recall date
December 4, 2024
Classification
Class II
Status
Terminated
Agency
FDA (drug)
Open FDA enforcement record Latest recalls